AFG
IMDX
Albion Financial Group’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22 | Hold |
7
| – | – | ﹤0.01% | 581 |
|
|
2025
Q1 | $22 | Hold |
7
| – | – | ﹤0.01% | 603 |
|
|
2024
Q4 | $17 | Hold |
7
| – | – | ﹤0.01% | 677 |
|
|
2024
Q3 | $20 | Hold |
7
| – | – | ﹤0.01% | 505 |
|
|
2024
Q2 | $21 | Hold |
7
| – | – | ﹤0.01% | 507 |
|
|
2024
Q1 | $21 | Hold |
7
| – | – | ﹤0.01% | 496 |
|
|
2023
Q4 | $18 | Hold |
7
| – | – | ﹤0.01% | 470 |
|
|
2023
Q3 | $22 | Sell |
7
-145
| -95% | -$3 | ﹤0.01% | 473 |
|
|
2023
Q2 | $35 | Hold |
152
| – | – | ﹤0.01% | 465 |
|
|
2023
Q1 | $54 | Hold |
152
| – | – | ﹤0.01% | 439 |
|
|
2022
Q4 | $49 | Hold |
152
| – | – | ﹤0.01% | 477 |
|
|
2022
Q3 | $0 | Hold |
152
| – | – | ﹤0.01% | 532 |
|
|
2022
Q2 | $0 | Hold |
152
| – | – | ﹤0.01% | 594 |
|
|
2022
Q1 | $0 | Hold |
152
| – | – | ﹤0.01% | 645 |
|
|
2021
Q4 | $0 | Hold |
152
| – | – | ﹤0.01% | 668 |
|
|
2021
Q3 | $1K | Hold |
152
| – | – | ﹤0.01% | 498 |
|
|
2021
Q2 | $1K | Buy |
+152
| New | +$1K | ﹤0.01% | 494 |
|
|
2020
Q4 | $0 | Buy |
+152
| New | – | ﹤0.01% | 499 |
|